Searle & Co’s Elevance Health ELV Stock Holding History

Searle & Co’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$877K	Sell	2,256 -250	-10%	-$100K	0.21%	88
2026 Q2	$969K	Buy	2,506 +150	+6%	+$55.6K	0.22%	86
2026 Q1	$690K	Sell	2,356 -250	-10%	-$82.2K	0.17%	108
2025 Q4	$914K	Hold	2,606	–	–	0.24%	85
2025 Q3	$842K	Hold	2,606	–	–	0.22%	92
2025 Q2	$1.01M	Hold	2,606	–	–	0.29%	75
2025 Q1	$1.13M	Sell	2,606 -220	-8%	-$88.3K	0.32%	72
2024 Q4	$1.04M	Hold	2,826	–	–	0.3%	73
2024 Q3	$1.47M	Hold	2,826	–	–	0.37%	60
2024 Q2	$1.53M	Buy	2,826 +49	+2%	+$25.9K	0.36%	63
2024 Q1	$1.44M	Sell	2,777 -13	-0.5%	-$6.46K	0.37%	63
2023 Q4	$1.32M	Sell	2,790 -75	-3%	-$34.7K	0.36%	65
2023 Q3	$1.25M	Hold	2,865	–	–	0.42%	59
2023 Q2	$1.35M	Buy	2,865 +75	+3%	+$34.6K	0.42%	60
2023 Q1	$1.31M	Sell	2,790 -500	-15%	-$238K	0.43%	57
2022 Q4	$1.69M	Hold	3,290	–	–	0.58%	50
2022 Q3	$1.49M	Hold	3,290	–	–	0.57%	51
2022 Q2	$1.59M	Hold	3,290	–	–	0.63%	49
2022 Q1	$1.62M	Hold	3,290	–	–	0.6%	53
2021 Q4	$1.52M	Hold	3,290	–	–	0.55%	57
2021 Q3	$1.23M	Hold	3,290	–	–	0.5%	61
2021 Q2	$1.26M	Hold	3,290	–	–	0.51%	60
2021 Q1	$1.18M	Hold	3,290	–	–	0.53%	59
2020 Q4	$1.06M	Hold	3,290	–	–	0.51%	58
2020 Q3	$884K	Sell	3,290 -50	-1%	-$13.5K	0.48%	59
2020 Q2	$878K	Hold	3,340	–	–	0.51%	56
2020 Q1	$758K	Buy	3,340 +500	+18%	+$136K	0.54%	56
2019 Q4	$858K	Buy	+2,840	New	+$782K	0.47%	62

Other funds holding ELV

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Searle & Co's ELV Position: Q3 2026 in Review

Searle & Co reduced its Elevance Health (ELV) stake by 10% in Q3 2026, selling an estimated $100K and leaving 2,256 shares worth $877K. The position accounts for 0.21% of the portfolio, ranked #88.

Searle & Co first reported a position in ELV in Q4 2019 and has held it in 28 quarters since. The position peaked at $1.69M in Q4 2022. 1,199 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

Searle & Co held 2,256 shares of Elevance Health worth $877K as of Q3 2026.
Searle & Co sold 250 Elevance Health shares in Q3 2026, an estimated $100K.
Elevance Health made up 0.21% of Searle & Co's portfolio in Q3 2026, its #88 holding.
Searle & Co first reported a position in Elevance Health in Q4 2019 and has held it in 28 quarters since.
Searle & Co's Elevance Health position peaked at $1.69M in Q4 2022.
1,199 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Searle & Co's 13F filing for Q3 2026, filed 4 Nov 2026.